Efficacy and safety of insulin glulisine in Japanese patients with type 1 diabetes mellitus: Using insulin glargine as basal insulin

被引：0
|
作者：
Kawamori, Ryuzo
Kadowaki, Takashi
Ishii, Hitoshi
Iwasaki, Manabu
Iwamoto, Yasuhiko
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A573 / A573
页数：1
相关论文
共 50 条
  • [31] Introducing insulin glulisine in patients with Type 2 diabetes treated with insulin glargine in a real life setting
    Rochlitz, H.
    Schaaf, N. S.
    Donaubauer, B.
    DIABETIC MEDICINE, 2008, 25
  • [32] Efficacy of insulin glargine in patients with type 1 and 2 diabetes
    Plauschinat, CA
    Cryar, AK
    Godley, PJ
    Nguyen, AB
    Browne, BA
    VALUE IN HEALTH, 2003, 6 (03) : 327 - 328
  • [33] ECONOMIC ANALYSIS OF GLARGINE INSULIN AND DETEMIR INSULIN IN PATIENTS WITH TYPE 1 DIABETES MELLITUS IN MEXICO
    Reyes-Lopez, A.
    Lemus, A.
    Acevedo, G. A. R.
    VALUE IN HEALTH, 2009, 12 (07) : A408 - A409
  • [34] Combining insulin glulisine with basal insulin glargine provides improved glycaemic control in patients with Type 2 diabetes in everyday clinical practice
    Donaubauer, B.
    Ferlinz, K.
    Schreiber, S.
    DIABETIC MEDICINE, 2008, 25
  • [35] Effect of exercise on Pharmacokinetics (PK) of Basal Insulin peglispro (BIL) and insulin Glargine (GL) in type 1 diabetes mellitus patients
    Linnebjerg, H.
    Lam, E.
    Choi, S.
    Knadler, M. P.
    Porksen, N.
    Sinha, V. P.
    Garhyan, P.
    Klein, O.
    Nosek, L.
    Heise, T.
    DIABETOLOGIA, 2015, 58 : S164 - S164
  • [36] Efficacy and Safety of a Basal-Bolus Regimen of Basal Insulin Plus Insulin Glulisine in Patients With Type 2 Diabetes: A Pooled Analysis of 5 Clinical Trials
    Dailey, George
    Lin, Jay
    Wang, Edward
    DIABETES, 2012, 61 : A284 - A284
  • [37] Effects of an intensified insulin therapy (ICT) with insulin glargine and insulin glulisine on patient reported outcomes (PRO) in diabetes mellitus
    Daikeler, R.
    Hoegy, B.
    Donaubauer, B.
    DIABETOLOGIE UND STOFFWECHSEL, 2007, 2 (05) : 308 - 314
  • [38] Similar efficacy and safety with LY2963016 insulin glargine compared with insulin glargine in patients with type 2 diabetes mellitus: the ELEMENT 2 study
    Hollander, P.
    Rosenstock, J.
    Bhargava, A.
    Ilag, L. L.
    Pollom, R. K.
    Huster, W. J.
    Prince, M. J.
    DIABETOLOGIA, 2014, 57 : S388 - S388
  • [39] Meta-analysis of Efficacy and Safety Outcomes Associated With the Basal-Plus Regimen of Insulin Glargine and Insulin Glulisine among Type 2 Diabetes Patients With HbA1c≥8%
    Raccah, Denis
    Lin, Jay
    Bahloul, Amar
    Wang, Edward
    Penfornis, Alfred
    DIABETES, 2012, 61 : A620 - A620
  • [40] Use of human insulin analogues in young patients with type 1 diabetes mellitus: Results of the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen
    Efremova, N. V.
    Bolotskaya, L. L.
    Atarshchikov, D. S.
    Bondarenko, O. N.
    Ilyin, A. V.
    Shestakova, M. V.
    TERAPEVTICHESKII ARKHIV, 2015, 87 (10) : 42 - 49
12345